Clinics in Dermatology
Volume 28, Issue 5 , Pages 489-496 , September 2010

Skin diseases associated with hepatitis C virus: Facts and controversies

  • Alfredo Rebora, MD

      Affiliations

    • Corresponding Author InformationTel.: +39 010 353 8414; fax: +39 010 353 8401.

References 

  1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20:1–16
  2. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Médécine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore). 2000;79:47–56
  3. Hermida M, Ferreiro MC, Barral S, et al. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test. J Virol Methods. 2002;101:29–35
  4. Jorgensen C, Legouffe MC, Perney P, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum. 1996;39:1166–1171
  5. Feucht HH, Polywka S, Zollner B, Laufs R. Greater amount of HCV-RNA in tears compared to blood. Microbiol Immunol. 1994;38:157–158
  6. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004;351:438–450
  7. Dickson RC. Clinical manifestations of hepatitis C. Clin Liver Dis. 1997;1:569–585
  8. Houghton M, Weiner A, Han J, et al. Molecular biology of the hepatitis C virus: Implications for the diagnosis, development and control of viral disease. Hepatology. 1991;14:381
  9. Sansonno D, Cornacchiulo V, Iacobelli AR, et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology. 1995;21:305–312
  10. Agnello A, Chung RT, Lee MK. A role for hepatitis C infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490–1495
  11. Schirren CA, Zachoval R, Schirren CGA. role for chronic hepatitis C infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease: Effective therapy with interferon-a. Dig Dis Sci. 1995;40:1221–1225
  12. Saadoun D, Delluc A, Piette JC, Cacoub P. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Curr Opin Rheumatol. 2008;20:23–28
  13. Toll A, Celis R, Ozalla MD, et al. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection. J Eur Acad Dermatol Venereol. 2006;20:1201–1216
  14. Rebora A. Lichen planus and the liver. Lancet. 1981;8250:805–806
  15. Mouly F, Pawlotsky JM, Schaeffer A, et al. Association of porphyria cutanea tarda and lichen planus in a patient with chronic hepatitis C virus infection. Br J Dermatol. 1995;132:158–159
  16. Rebora A, Rongioletti F, Drago F. Parodi. Lichen planus as a side effect of HBV vaccination. Dermatology. 1999;198:1–2
  17. Carrozzo M, Gandolfo S, Carbone M, et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med. 1996;25:527–533
  18. del Olmo JA, Pascual I, Bagan JV, et al. Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease. Eur J Oral Sci. 2000;108:378–382
  19. Gandolfo S, Carbone M, Carrozzo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med. 1994;23:119–122
  20. Mignogna MD, Lo Muzio L, Lo Russo L, et al. Oral lichen planus: different clinical features in HCV-positive and HCV-negative patients. Int J Dermatol. 2000;39:134–139
  21. Divano MC, Parodi A, Rebora A. Lichen planus, liver kidney microsomal (LKM1) antibodies and hepatitis C virus antibodies. Dermatology. 1992;185:132–133
  22. Rebora A. Hepatitis viruses and lichen planus. Arch Dermatol. 1994;130:1328–1329
  23. Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. [letter] Lancet. 1995;8984:1234
  24. Gimenez-Arnau A, Alayon-Lopez C, Camarasa JG. Lichen planus and hepatitis C. [abstract] J Eur Acad Dermatol Venereol. 1995;5:S84–85
  25. Nagao Y, Sata M, Tanikawa K, et al. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest. 1995;25:910–914
  26. Schmitt EC, Mozzanica N, Finzi AF, et al. Hepatitis C viremia in erosive and classic lichen planus. [abstract] J Eur Acad Dermatol Venereol. 1995;5:S84
  27. Tanei R, Watanabe K, Nishiyama S. Clinical and histopathological analysis of the relationship between lichen planus and chronic hepatitis C. J Dermatol. 1995;22:316–323
  28. Sanchez-Perez J, De Castro M, Buezo GF, et al. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol. 1996;134:715–719
  29. Serpico R, Busciolano M, Femiano F. A statistical epidemiological study of a possible correlation between serum transaminase levels and viral hepatic pathology markers and lichen planus orale. Minerva Stomatol. 1997;46:97–102
  30. Bagan JV, Ramon C, Gonzales L, et al. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Radiol Endod. 1998;85:532–536
  31. Mignogna MD, Lo Muzio L, Favia G, et al. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol. 1998;37:575–578
  32. Chuang TY, Stitle L, Brashear R, Lewis C. Hepatitis C virus and lichen planus: a case-control study of 340 patients. J Am Acad Dermatol. 1999;41:787–789
  33. Rossi L, Colasanto S. Clinical considerations and statistical analysis on 100 patients with oral lichen planus. Minerva Stomatol. 2000;49:393–398
  34. Beaird LM, Kahloon N, Franco J, Fairley JA. Incidence of hepatitis C in lichen planus. J Am Acad Dermatol. 2001;44:311–312
  35. Chainani-Wu N, Silverman S, Lozada-Nur F, et al. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc. 2001;132:901–909
  36. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207–214
  37. Figueiredo LC, Carrilho FJ, de Andrade HF, Migliari DA. Oral lichen planus and hepatitis C virus infection. Oral Dis. 2002;8:42–46
  38. Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol. 1994;31:1070–1072
  39. Dupin N, Chosidow O, Lunel F, et al. Oral lichen planus and hepatitis C virus infection: a fortuitous association?. Arch Dermatol. 1997;133:1052–1053
  40. Dupond AS, Lacour JP, Lafont C, Ortonne JP. Prevalence of hepatitis C virus in oral erosive lichen. Ann Dermatol Venereol. 1998;125:676–678
  41. Imhof M, Popal H, Lee JH, et al. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus. Dermatology. 1997;195:1–5
  42. Grote M, Reichart PA, Berg T, et al. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol. 1998;29:1034–1035
  43. Ilter N, Senol E, Gurer MA, Altay O. Lichen planus and hepatitis C-virus infection in Turkish patients. J Eur Acad Dermatol Venereol. 1998;10:192–193
  44. Kirtak N, Inaloz HS. Ozgoztasi, Erbagci Z. The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Eur J Epidemiol. 2000;16:1159–1161
  45. Erkek E, Bozdogan Ö, Olut AI. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol. 2001;26:540–544
  46. Ingafou M, Porter SR, Scully C, Teo CG. No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg. 1998;27:65–66
  47. Tucker SC, Coulson ICH. Lichen planus is not associated with hepatitis C virus infection in patients from north west England. Acta Derm Venereol. 1999;79:378–379
  48. Roy K, Bagg J. Hepatitis C virus and oral disease: a critical review. Oral Dis. 1999;5:270–277
  49. van der Meij EH, van der Waal I. Hepatitis C virus infection and oral lichen planus: a report from The Netherlands. J Oral Pathol Med. 2000;29:255–258
  50. Ibrahim HA, Baddour MM, Morsi MG, Abdelkader AA. Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis?. East Mediterr Health J. 1999;5:71–78
  51. Mignogna MD, Fedele S, Lo Russo L, et al. Unexpected low incidence of oral lichen planus in an HCV hyperendemic area of Southern Italy. Gastroenterology. 2001;121:1528–1529
  52. Pawlotsky JM, Benchiki H, Pellet C, et al. Lichen planus and HCV genotypes. Br J Dermatol. 1995;133:666–667
  53. Lodi G, Carrozzo M, Hallett R, et al. HCV-genotypes in Italian patients with HCV related oral lichen planus. J Oral Pathol Med. 1997;26:381–384
  54. Nagao Y, Sata M, Itoh K, et al. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest. 1996;26:495–498
  55. La Nasa G, Cottoni F, Mulargia M, et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol. 1995;132:897–900
  56. Carrozzo M, Francia di Celle P, Gandolfo S, et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus associated oral lichen planus. Br J Dermatol. 2001;144:803–808
  57. Boyd AS, Nanney LB, King LE. Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Int J Dermatol. 1998;37:260–262
  58. Arrieta JJ, Rodriguez-Inigo E, Casqueiro M, et al. Detection of hepatitis C virus replication by in situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology. 2000;32:97–103
  59. Nagao Y, Sata M, Noguchi S, et al. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med. 2000;29:259–266
  60. Carrozzo M, Quadri R, Latorre P, et al. Molecular evidence that hepatitis C virus replicates in the oral mucosa. J Hepatol. 2002;37:364–369
  61. Pilli M, Vescovi P, Manfredi M, et al. Oral lichen planus infiltrating T cells: a pathogenetic role for HCV-specific T cell responses?. [abstract] In: Proceedings of the 8th International Symposium on Hepatitis C Virus and Related Viruses, Paris, September 2-5. 2001;p. 34
  62. Harden D, Skelton H, Smith KJ. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus. J Am Acad Dermatol. 2003;49:847–852
  63. Lodi G, Olsen I, Piattelli A, et al. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection. J Oral Pathol Med. 1997;26:36–39
  64. Nagao Y, Sata M, Abe K, et al. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol. 1997;32:324–329
  65. Fleischmann M, Celerier P, Bernard P, et al. Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology. 1996;192:50–55
  66. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med. 2003;14:115–127
  67. Parodi A, Cozzani E, Massone C, et al. Prevalence of stratified epithelium-specific antinuclear antibodies in 138 patients with lichen planus. J Am Acad Dermatol. 2007;56:974–978
  68. Carson CW, Conn DL, Czaja AJ, et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol. 1993;20:304–309
  69. Hortelano Martínez E, Calvo Catalá J, Gonzalez-Cruz Cervellera MI, et al. Polyarteritis nodosa associated with hepatitis C virus. [Abstract] An Med Interna. 1997;14:241–243
  70. Pawlotsky JM, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 1994;19:841–848
  71. Loustaud-Ratti V, Riche A, Liozon E, et al. Prevalence and characteristics of Sjögren’s syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol. 2001;28:2245–2251
  72. Ramos-Casals M, Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol. 2005;17:447–455
  73. Pirisi M, Scott C, Fabris C, et al. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol. 1994;29:940–942
  74. Scott CA, Avellini C, Desinan L, et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren’s syndrome. Histopathology. 1997;30:41–48
  75. Yamamoto T, Katayama I, Nishioka K. Psoriasis and hepatitis C virus. Acta Derm Venereol. 1995;75:482–483
  76. Chouela E, Abeldano A, Panetta J, et al. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol. 1996;35:797–799
  77. Burrows NP, Norris PG, Alexander G, Wreghitt T. Chronic hepatitis C infection and psoriasis. [letter] Dermatology. 1995;190:173
  78. Citro V, Fristachi R, Tarantino G. Extensive psoriasis induced by pegylated interferon: a case report. J Med Case Rep. 2007;1:86
  79. Soylu S, Gül U, Kiliç A. Cutaneous manifestations in patients positive for anti-hepatitis C virus antibodies. Acta Derm Venereol. 2007;87:49–53
  80. Kanazawa K, Yaoita H, Tsuda F, et al. Association of prurigo with hepatitis C virus infection. Arch Dermatol. 1995;131:852–853
  81. Nagao Y, Sata M, Tanikawa K, et al. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med. 1995;24:354–360
  82. Nagao Y, Sata M, Fukuizumi K, et al. Oral cancer and hepatitis C virus (HCV): can HCV alone cause oral cancer?—a case report. Kurume Med J. 1996;43:97–100
  83. Nagao Y, Sata M, Noguchi S, et al. Various extrahepatic manifestations caused by hepatitis C virus infection. Int J Mol Med. 1999;4:621–625
  84. Carrozzo M, Carbone M, Gandolfo S, et al. An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol. 1997;33:220–225
  85. Porter SR, Lodi G, Chandler K, Kumar N. Development of squamous cell carcinoma in hepatitis C virus-associated lichen planus. Oral Oncol. 1997;33:58–59
  86. Cervoni E. Hepatitis C. Lancet. 1998;9099:1209–1210
  87. Lo Muzio L, Mignogna MD, Favia G, et al. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol. 1998;34:239–246
  88. Nagao Y, Sata M, Fukuizumi K, et al. High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. Hepatol Res. 1997;8:173–177
  89. Fujimoto T, Tomimatsu M, Iga D, et al. Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C. J Gastroenterol Hepatol. 2008;23:e432–e437
  90. Descamps V. Manifestations cutanées au cours des traitements par interféron. Presse Med. 2005;34:1668–1672

PII: S0738-081X(10)00028-3

doi: 10.1016/j.clindermatol.2010.03.004

Clinics in Dermatology
Volume 28, Issue 5 , Pages 489-496 , September 2010

Article Tools